Cell motility was more asymmetric at CCL19 concentrations close to the CCR7 dynamic kinetic binding constant, suggesting that CCL19 is involved in regulating tumor cell heterogeneity and invasive ability in the breast cancer microenvironment [30]. This evidence concerns the gene CCL19 and breast carcinoma.